Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31851 - 31875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	MXI1	4601	downregulated	Cisplatin results in decreased expression of MXI1 mRNA	10q25.2	A20427
Cisplatin	Approved Investigational	MYC	4609	downregulated	Cisplatin results in decreased expression of MYC mRNA	8q24.21	A22210 A21978
Cisplatin	Approved Investigational	MYH10	4628	downregulated	Cisplatin results in decreased expression of MYH10 mRNA	17p13.1	A22204
Cisplatin	Approved Investigational	NAIP	4671	downregulated	Cisplatin results in decreased expression of NAIP mRNA	5q13.2	A22227
Cisplatin	Approved Investigational	NANOG	79923	downregulated	Cisplatin results in decreased expression of NANOG mRNA	12p13.31	A21978
Cisplatin	Approved Investigational	NANOG	79923	upregulated	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NANOG mRNA	12p13.31	A22232
Cisplatin	Approved Investigational	NANOG	79923	upregulated	Cisplatin results in increased expression of NANOG mRNA	12p13.31	A22239
Cisplatin	Approved Investigational	NARS	4677	downregulated	Cisplatin results in decreased expression of NARS mRNA	18q21.31	A20427
Cisplatin	Approved Investigational	NAV1	89796	downregulated	Cisplatin results in decreased expression of NAV1 mRNA	1q32.1	A22204
Cisplatin	Approved Investigational	NAV2	89797	downregulated	Cisplatin results in decreased expression of NAV2 mRNA	11p15.1	A22204
Cisplatin	Approved Investigational	NCBP2	22916	upregulated	Cisplatin results in increased expression of NCBP2 mRNA	3q29	A22204
Cisplatin	Approved Investigational	NEDD4L	23327	downregulated	Cisplatin results in decreased expression of NEDD4L mRNA	18q21.31	A22204
Cisplatin	Approved Investigational	NEDD9	4739	downregulated	Cisplatin results in decreased expression of NEDD9 mRNA	6p24.2	A20427
Cisplatin	Approved Investigational	NES	10763	upregulated	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NES mRNA	1q23.1	A22232
Cisplatin	Approved Investigational	NFIB	4781	downregulated	Cisplatin results in decreased expression of NFIB mRNA	9p23-p22.3	A22204
Cisplatin	Approved Investigational	NFIC	4782	downregulated	Cisplatin results in decreased expression of NFIC mRNA	19p13.3	A22204
Cisplatin	Approved Investigational	NHS	4810	downregulated	Cisplatin results in decreased expression of NHS mRNA	Xp22.2-p22.13	A22204
Cisplatin	Approved Investigational	NIFK	84365	upregulated	Cisplatin results in increased expression of NIFK mRNA	2q14.3	A22204
Cisplatin	Approved Investigational	NIN	51199	downregulated	Cisplatin results in decreased expression of NIN mRNA	14q22.1	A20427
Cisplatin	Approved Investigational	NINJ1	4814	upregulated	Cisplatin results in increased expression of NINJ1 mRNA	9q22.31	A22212 A20427
Cisplatin	Approved Investigational	NKX2-5	1482	upregulated	Cisplatin results in increased expression of NKX2-5 mRNA	5q34	A22204
Cisplatin	Approved Investigational	NKX3-1	4824	upregulated	Cisplatin results in increased expression of NKX3-1 mRNA	8p21.2	A22204
Cisplatin	Approved Investigational	NMB	4828	upregulated	Cisplatin results in increased expression of NMB mRNA	15q25.2	A22203
Cisplatin	Approved Investigational	NOCT	25819	upregulated	Cisplatin results in increased expression of NOCT mRNA	4q31.1	A22204
Cisplatin	Approved Investigational	NOD1	10392	upregulated	Cisplatin results in increased expression of NOD1 mRNA	7p14.3	A22236

Displaying entries 31851 - 31875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability